BT
GSK icon

Beacon Trust’s GSK GSK Stock Holding History

Beacon Trust’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-8,364
Closed -$422K – 186
2015
Q4 		$422K Sell
8,364
-540
-6% -$27.5K 0.07% 131
2015
Q3 		$428K Sell
8,904
-758
-8% -$39.5K 0.08% 133
2015
Q2 		$503K Sell
9,662
-8,339
-46% -$470K 0.08% 128
2015
Q1 		$1.04M Sell
18,001
-946
-5% -$54.2K 0.16% 106
2014
Q4 		$1.01M Buy
18,947
+13,220
+231% +$740K 0.16% 108
2014
Q3 		$329K Sell
5,727
-431
-7% -$26.4K 0.05% 151
2014
Q2 		$411K Sell
6,158
-340
-5% -$23K 0.07% 139
2014
Q1 		$434K Sell
6,498
-80
-1% -$5.41K 0.07% 134
2013
Q4 		$439K Buy
6,578
+1,821
+38% +$118K 0.08% 132
2013
Q3 		$299K Hold
4,757
– – 0.06% 143
2013
Q2 		$298K Buy
+4,757
New +$302K 0.06% 144

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Beacon Trust's GSK Position: Q1 2016 in Review

Beacon Trust sold out of GSK (GSK) in Q1 2016, closing a stake of 8,364 shares — an estimated $422K sold.

Beacon Trust first reported a position in GSK in Q2 2013 and held it in 11 quarters. The position peaked at $1.04M in Q1 2015. 726 funds tracked by Wall St. Rank hold GSK as of Q1 2016.

  • Beacon Trust reported no remaining GSK position as of Q1 2016 after selling out during the quarter.
  • Beacon Trust sold 8,364 GSK shares in Q1 2016, an estimated $422K.
  • Beacon Trust first reported a position in GSK in Q2 2013 and held it in 11 quarters.
  • Beacon Trust's GSK position peaked at $1.04M in Q1 2015.
  • 726 funds tracked by Wall St. Rank held GSK as of Q1 2016.

Based on Beacon Trust's 13F filing for Q1 2016, filed 20 Jun 2016.